Skip to main content

Knowledge for Growth 2019

Various members, including our senior leadership team, will be present at the event and are excited to network with leading experts in the healthcare field. Additionally, our design and engineering partner Voxdale, has a booth at the conference and will showcase our unique medical devices Colli-Pee™, an easy-to-use urine sampling tool, and VAX-ID™, an intradermal injection system.

We look forward to seeing you!

Disclaimer

Novosanis is a wholly owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology. The Colli-Pee® family, the heart of the company, allows volumetric and standardized collection of first-void urine. The platform consists of variants capturing a range of urine volumes for different application purposes. Urine collection through the Colli-Pee® device is easy, comfortable, and more accurate than a regular urine cup. First-void urine has shown to improve detection of infectious diseases, including sexually transmitted infections as well as for some cancers applications. The Colli-Pee® device enables immediate mixing of the first-void urine sample with a preservative, improving stability of the urine specimen. Novosanis markets its products worldwide and has a global customer base.